These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30923407)

  • 21. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia and warfarin-induced skin necrosis: case report.
    Kaiber FL; Malucelli TO; Baroni Edo R; Schafranski MD; Akamatsu HT; Schmidt CC
    An Bras Dermatol; 2010; 85(6):915-8. PubMed ID: 21308322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin-Induced Skin Necrosis Despite Enoxaparin Bridging Therapy.
    Wali M; Latif MT; Lockwood M; Saeyeldin A; Borz-Baba C
    Cureus; 2022 Jan; 14(1):e20883. PubMed ID: 35145788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sepsis Causing Acquired Protein C and Protein S Deficiency.
    Kannan A; Chandra S; Lizcano J; Murphy C
    JNMA J Nepal Med Assoc; 2014; 52(193):729-31. PubMed ID: 26905558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of optimal anticoagulation therapy on chronic venous ulcer healing in thrombophilic patients with post-thrombotic syndrome.
    Hinojosa CA; Olivares-Cruz S; Laparra-Escareno H; Sanchez-Castro S; Tamayo-Garcia B; Anaya-Ayala JE
    J Wound Care; 2016 Dec; 25(12):756-759. PubMed ID: 27974007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian malignancy unmasked by venous gangrene in a patient on warfarin therapy: a case report.
    Said A; Keasberry J
    J Med Case Rep; 2016 Jun; 10(1):151. PubMed ID: 27264137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.
    Goldstein JN; Thomas SH; Frontiero V; Joseph A; Engel C; Snider R; Smith EE; Greenberg SM; Rosand J
    Stroke; 2006 Jan; 37(1):151-5. PubMed ID: 16306465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep vein thrombosis outcome and the level of oral anticoagulation therapy.
    Caprini JA; Arcelus JI; Reyna JJ; Motykie GD; Mohktee D; Zebala LP; Cohen EB
    J Vasc Surg; 1999 Nov; 30(5):805-11. PubMed ID: 10550177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probable Interaction Between Warfarin and Banana Flakes Supplement.
    King AE; Strnad K
    Nutr Clin Pract; 2016 Feb; 31(1):125-31. PubMed ID: 26137942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiency.
    Ng T; Tillyer ML
    Clin Lab Haematol; 2001 Aug; 23(4):261-4. PubMed ID: 11683790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of low-dose prothrombin complex concentrate before lumbar puncture.
    Butler JJ
    Am J Health Syst Pharm; 2015 Feb; 72(3):203-5. PubMed ID: 25596603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S.
    Gailani D; Reese EP
    Am J Hematol; 1999 Mar; 60(3):231-6. PubMed ID: 10072117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation therapy for thromboembolism prevention: a case of warfarin-induced skin necrosis in the setting of protein C deficiency.
    Lai J; Ramai D; Alchi R; Bloomfield D
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28500260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin skin necrosis: recurrence in the absence of anticoagulant therapy.
    Humphries JE; Gardner JH; Connelly JE
    Am J Hematol; 1991 Jul; 37(3):197-200. PubMed ID: 1858772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.